Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Clin Cancer Res · 2026 · PMC13012252 · PMID 41493770

Europe PMC DOI

hedged sentence

0.0270

closest p · 0.5× alpha

0.0270

boldest claim

The sentences

showed a trendP = 0,027actually significant

7.4 months; HR, 0.63; P = 0.0006) and showed a trend toward improved OS (29.2 vs. 23.0 months; HR, 0.70; P = 0,027), but data are immature.

also in 22,539 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.